▶ 調査レポート

次世代薬剤溶出ステントの世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Next-Generation Drug-Eluting Stent Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。次世代薬剤溶出ステントの世界市場2020年:メーカー別、地域別、種類・用途別 / Global Next-Generation Drug-Eluting Stent Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0GIR-11362資料のイメージです。• レポートコード:D0GIR-11362
• 出版社/出版日:GlobalInfoResearch / 2020年9月23日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、次世代薬剤溶出ステントの世界市場を広く調査・分析し、今後の市場展望をまとめております。次世代薬剤溶出ステントの種類別市場規模(コバルトクロム、ステンレス、その他)、用途別市場規模(病院、クリニック、外来手術センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Abbott、Sorin Group、Biosensors International、Medtronic、Terumo、SMT
・地域別グローバル市場分析 2015年-2020年
・次世代薬剤溶出ステントの北米市場(アメリカ、カナダ、メキシコ)
・次世代薬剤溶出ステントのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・次世代薬剤溶出ステントのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・次世代薬剤溶出ステントの南米市場(ブラジル、アルゼンチン)
・次世代薬剤溶出ステントの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:コバルトクロム、ステンレス、その他
・用途別分析:病院、クリニック、外来手術センター
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Next-Generation Drug-Eluting Stent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Next-Generation Drug-Eluting Stent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Next-Generation Drug-Eluting Stent market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Next-Generation Drug-Eluting Stent market has been segmented into
Cobalt Chromium
Stainless Steel
Others

By Application, Next-Generation Drug-Eluting Stent has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Next-Generation Drug-Eluting Stent market presented in the report. This section sheds light on the sales growth of different regional and country-level Next-Generation Drug-Eluting Stent markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Next-Generation Drug-Eluting Stent market.

The report offers in-depth assessment of the growth and other aspects of the Next-Generation Drug-Eluting Stent market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Next-Generation Drug-Eluting Stent Market Share Analysis
Next-Generation Drug-Eluting Stent competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Next-Generation Drug-Eluting Stent sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Next-Generation Drug-Eluting Stent sales, revenue and market share for each player covered in this report.

The major players covered in Next-Generation Drug-Eluting Stent are:
Abbott
Sorin Group
Biosensors International
Medtronic
Terumo
SMT

Among other players domestic and global, Next-Generation Drug-Eluting Stent market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Next-Generation Drug-Eluting Stent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Next-Generation Drug-Eluting Stent, with price, sales, revenue and global market share of Next-Generation Drug-Eluting Stent in 2018 and 2019.
Chapter 3, the Next-Generation Drug-Eluting Stent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Next-Generation Drug-Eluting Stent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Next-Generation Drug-Eluting Stent market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Next-Generation Drug-Eluting Stent sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Next-Generation Drug-Eluting Stent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Next-Generation Drug-Eluting Stent Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cobalt Chromium
1.2.3 Stainless Steel
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Next-Generation Drug-Eluting Stent Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Overview of Global Next-Generation Drug-Eluting Stent Market
1.4.1 Global Next-Generation Drug-Eluting Stent Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sorin Group
2.2.1 Sorin Group Details
2.2.2 Sorin Group Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sorin Group SWOT Analysis
2.2.4 Sorin Group Product and Services
2.2.5 Sorin Group Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biosensors International
2.3.1 Biosensors International Details
2.3.2 Biosensors International Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biosensors International SWOT Analysis
2.3.4 Biosensors International Product and Services
2.3.5 Biosensors International Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Medtronic SWOT Analysis
2.4.4 Medtronic Product and Services
2.4.5 Medtronic Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Terumo
2.5.1 Terumo Details
2.5.2 Terumo Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Terumo SWOT Analysis
2.5.4 Terumo Product and Services
2.5.5 Terumo Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 SMT
2.6.1 SMT Details
2.6.2 SMT Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 SMT SWOT Analysis
2.6.4 SMT Product and Services
2.6.5 SMT Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Next-Generation Drug-Eluting Stent Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Next-Generation Drug-Eluting Stent Manufacturer Market Share in 2019
3.3.2 Top 6 Next-Generation Drug-Eluting Stent Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Regions
4.1.1 Global Next-Generation Drug-Eluting Stent Sales and Market Share by Regions (2015-2020)
4.1.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Regions (2015-2020)
4.2 North America Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
4.3 Europe Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
4.5 South America Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Country
5.1.1 North America Next-Generation Drug-Eluting Stent Sales and Market Share by Country (2015-2020)
5.1.2 North America Next-Generation Drug-Eluting Stent Revenue and Market Share by Country (2015-2020)
5.2 United States Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
5.3 Canada Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
5.4 Mexico Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Country
6.1.1 Europe Next-Generation Drug-Eluting Stent Sales and Market Share by Country (2015-2020)
6.1.2 Europe Next-Generation Drug-Eluting Stent Revenue and Market Share by Country (2015-2020)
6.2 Germany Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
6.3 UK Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
6.4 France Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
6.5 Russia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
6.6 Italy Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Next-Generation Drug-Eluting Stent Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Next-Generation Drug-Eluting Stent Revenue and Market Share by Regions (2015-2020)
7.2 China Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
7.3 Japan Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
7.4 Korea Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
7.5 India Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
7.7 Australia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Country
8.1.1 South America Next-Generation Drug-Eluting Stent Sales and Market Share by Country (2015-2020)
8.1.2 South America Next-Generation Drug-Eluting Stent Revenue and Market Share by Country (2015-2020)
8.2 Brazil Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
8.3 Argentina Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Next-Generation Drug-Eluting Stent Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Next-Generation Drug-Eluting Stent Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
9.3 Turkey Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
9.4 Egypt Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
9.5 South Africa Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Next-Generation Drug-Eluting Stent Sales and Market Share by Type (2015-2020)
10.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Type (2015-2020)
10.3 Global Next-Generation Drug-Eluting Stent Price by Type (2015-2020)
11 Global Next-Generation Drug-Eluting Stent Market Segment by Application
11.1 Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2015-2020)
11.2 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2015-2020)
11.3 Global Next-Generation Drug-Eluting Stent Price by Application (2015-2020)
12 Market Forecast
12.1 Global Next-Generation Drug-Eluting Stent Sales, Revenue and Growth Rate (2021-2025)
12.2 Next-Generation Drug-Eluting Stent Market Forecast by Regions (2021-2025)
12.2.1 North America Next-Generation Drug-Eluting Stent Market Forecast (2021-2025)
12.2.2 Europe Next-Generation Drug-Eluting Stent Market Forecast (2021-2025)
12.2.3 Asia-Pacific Next-Generation Drug-Eluting Stent Market Forecast (2021-2025)
12.2.4 South America Next-Generation Drug-Eluting Stent Market Forecast (2021-2025)
12.2.5 Middle East & Africa Next-Generation Drug-Eluting Stent Market Forecast (2021-2025)
12.3 Next-Generation Drug-Eluting Stent Market Forecast by Type (2021-2025)
12.3.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Type (2021-2025)
12.3.2 Global Next-Generation Drug-Eluting Stent Market Share Forecast by Type (2021-2025)
12.4 Next-Generation Drug-Eluting Stent Market Forecast by Application (2021-2025)
12.4.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Application (2021-2025)
12.4.2 Global Next-Generation Drug-Eluting Stent Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Next-Generation Drug-Eluting Stent Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Next-Generation Drug-Eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Next-Generation Drug-Eluting Stent Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Next-Generation Drug-Eluting Stent Major Business
Table 9. Abbott Next-Generation Drug-Eluting Stent Total Revenue (USD Million) (2018-2019)
Table 10. Abbott SWOT Analysis
Table 11. Abbott Next-Generation Drug-Eluting Stent Product and Services
Table 12. Abbott Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sorin Group Basic Information, Manufacturing Base and Competitors
Table 14. Sorin Group Next-Generation Drug-Eluting Stent Major Business
Table 15. Sorin Group Next-Generation Drug-Eluting Stent Total Revenue (USD Million) (2018-2019)
Table 16. Sorin Group SWOT Analysis
Table 17. Sorin Group Next-Generation Drug-Eluting Stent Product and Services
Table 18. Sorin Group Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biosensors International Basic Information, Manufacturing Base and Competitors
Table 20. Biosensors International Next-Generation Drug-Eluting Stent Major Business
Table 21. Biosensors International Next-Generation Drug-Eluting Stent Total Revenue (USD Million) (2018-2019)
Table 22. Biosensors International SWOT Analysis
Table 23. Biosensors International Next-Generation Drug-Eluting Stent Product and Services
Table 24. Biosensors International Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Medtronic Basic Information, Manufacturing Base and Competitors
Table 26. Medtronic Next-Generation Drug-Eluting Stent Major Business
Table 27. Medtronic Next-Generation Drug-Eluting Stent Total Revenue (USD Million) (2018-2019)
Table 28. Medtronic SWOT Analysis
Table 29. Medtronic Next-Generation Drug-Eluting Stent Product and Services
Table 30. Medtronic Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Terumo Basic Information, Manufacturing Base and Competitors
Table 32. Terumo Next-Generation Drug-Eluting Stent Major Business
Table 33. Terumo Next-Generation Drug-Eluting Stent Total Revenue (USD Million) (2018-2019)
Table 34. Terumo SWOT Analysis
Table 35. Terumo Next-Generation Drug-Eluting Stent Product and Services
Table 36. Terumo Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. SMT Basic Information, Manufacturing Base and Competitors
Table 38. SMT Next-Generation Drug-Eluting Stent Major Business
Table 39. SMT Next-Generation Drug-Eluting Stent Total Revenue (USD Million) (2018-2019)
Table 40. SMT SWOT Analysis
Table 41. SMT Next-Generation Drug-Eluting Stent Product and Services
Table 42. SMT Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Next-Generation Drug-Eluting Stent Sales by Manufacturer (2018-2019) (K Units)
Table 44. Global Next-Generation Drug-Eluting Stent Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Next-Generation Drug-Eluting Stent Sales by Regions (2015-2020) (K Units)
Table 46. Global Next-Generation Drug-Eluting Stent Sales Market Share by Regions (2015-2020)
Table 47. Global Next-Generation Drug-Eluting Stent Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Next-Generation Drug-Eluting Stent Sales by Countries (2015-2020) (K Units)
Table 49. North America Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2015-2020)
Table 50. North America Next-Generation Drug-Eluting Stent Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2015-2020)
Table 52. Europe Next-Generation Drug-Eluting Stent Sales by Countries (2015-2020) (K Units)
Table 53. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2015-2020)
Table 54. Europe Next-Generation Drug-Eluting Stent Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Next-Generation Drug-Eluting Stent Sales by Regions (2015-2020) (K Units)
Table 56. Asia-Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Next-Generation Drug-Eluting Stent Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Next-Generation Drug-Eluting Stent Sales by Countries (2015-2020) (K Units)
Table 59. South America Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2015-2020)
Table 60. South America Next-Generation Drug-Eluting Stent Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Countries (2015-2020) (K Units)
Table 63. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2015-2020)
Table 66. Global Next-Generation Drug-Eluting Stent Sales by Type (2015-2020) (K Units)
Table 67. Global Next-Generation Drug-Eluting Stent Sales Share by Type (2015-2020)
Table 68. Global Next-Generation Drug-Eluting Stent Revenue by Type (2015-2020) (USD Million)
Table 69. Global Next-Generation Drug-Eluting Stent Revenue Share by Type (2015-2020)
Table 70. Global Next-Generation Drug-Eluting Stent Sales by Application (2015-2020) (K Units)
Table 71. Global Next-Generation Drug-Eluting Stent Sales Share by Application (2015-2020)
Table 72. Global Next-Generation Drug-Eluting Stent Sales Forecast by Regions (2021-2025) (K Units)
Table 73. Global Next-Generation Drug-Eluting Stent Market Share Forecast by Regions (2021-2025)
Table 74. Global Next-Generation Drug-Eluting Stent Sales Forecast by Type (2021-2025) (K Units)
Table 75. Global Next-Generation Drug-Eluting Stent Market Share Forecast by Type (2021-2025)
Table 76. Global Next-Generation Drug-Eluting Stent Sales Forecast by Application (2021-2025)
Table 77. Global Next-Generation Drug-Eluting Stent Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Next-Generation Drug-Eluting Stent Picture
Figure 2. Global Sales Market Share of Next-Generation Drug-Eluting Stent by Type in 2019
Figure 3. Cobalt Chromium Picture
Figure 4. Stainless Steel Picture
Figure 5. Others Picture
Figure 6. Next-Generation Drug-Eluting Stent Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Global Next-Generation Drug-Eluting Stent Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Next-Generation Drug-Eluting Stent Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturer in 2019
Figure 31. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Next-Generation Drug-Eluting Stent Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Next-Generation Drug-Eluting Stent Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Next-Generation Drug-Eluting Stent Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Regions (2015-2020)
Figure 38. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Regions in 2018
Figure 39. North America Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
Figure 40. Europe Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
Figure 42. South America Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020)
Figure 44. North America Next-Generation Drug-Eluting Stent Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2015-2020)
Figure 46. North America Next-Generation Drug-Eluting Stent Sales Market Share by Countries in 2018
Figure 47. North America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries in 2018
Figure 49. United States Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Next-Generation Drug-Eluting Stent Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Countries in 2019
Figure 55. Germany Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Next-Generation Drug-Eluting Stent Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Regions 2019
Figure 63. China Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Next-Generation Drug-Eluting Stent Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Next-Generation Drug-Eluting Stent Sales Market Share by Countries in 2019
Figure 70. South America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries in 2019
Figure 71. Brazil Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Next-Generation Drug-Eluting Stent Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Next-Generation Drug-Eluting Stent Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Next-Generation Drug-Eluting Stent Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Next-Generation Drug-Eluting Stent Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Next-Generation Drug-Eluting Stent Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Next-Generation Drug-Eluting Stent Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Next-Generation Drug-Eluting Stent Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Next-Generation Drug-Eluting Stent Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel